Table 4

Pooled effect estimates for the symptoms related to the lower respiratory tract (excluding cough alone) either as a composite endpoint (lower respiratory symptoms, LRS) or wheeze where n represents the number of studies and p values derive from the Q combinality test for homogeneity between study effect estimates

PollutantMethod of pooling or subgroupMultiplicative change in symptom odds per unit (μg.m−3) increase in pollutantExpected impact on symptom odds of a 50 μg.m−3 rise in pollutantQ test p valuen
Pooled effect estimate95% confidence interval
*Number greater than the total number of studies as some studies present results separately for symptomatic and non-symptomatic/asthmatic children.
PM2.5Overall pooled effect estimate
    Fixed effects model1.0041.0021.0061.22<0.055
    Random effects model1.0091.0021.0161.57
PM10Overall pooled effect estimate
    Fixed effects model1.0011.0001.0011.05<0.00116
    Random effects model1.0041.0021.0051.2216
Subgroups based on outcome measures (fixed effects models)
    Symptom prevalence only1.0011.0001.0011.05<0.00113
    Composite LRS outcomes only1.0011.0001.0011.05<0.00111
Subgroups based on the population studied (fixed effects models)
    Asthmatic or symptomatic children1.0011.0001.0011.05<0.00112*
    Non-symptomatic children1.0041.0021.0061.22<0.0016*
Subgroups based on environmental conditions (fixed effects models)
    High ozone levels1.0091.0051.0141.57<0.0014
    High SO2 levels1.0000.9991.0011.00<0.0013
    High PM10 levels only1.0011.0011.0021.05<0.00111
Subgroups based on pollutant lag (fixed effects models)
    Same day or prior two days1.0011.0001.0011.05<0.00113
Subgroups based on analytical approach (fixed effects models)
    Use of a two-stage approach1.0041.0001.0071.22<0.1004
    Use of a population daily average outcome1.0011.0001.0011.05<0.00112
    Autocorrelation modelled using GEE1.0051.0031.0061.28<0.0017
    Autocorrelation not modelled using GEE1.0011.0001.0011.05<0.0019